Health
Vol.5 No.12(2013), Paper ID 40471, 7
pages
DOI:10.4236/health.2013.512262
Optimal needle insertion length for intramuscular injection of risperidone long-acting injectable (RLAI)
Tetsuya Tanioka, Sakiko Sakamaki, Yuko Yasuhara, Masahito Tomotake, Kensaku Takase, Chie Watari, Kouichi Makiguchi, Rozzano Locsin, Kazushi Motoki, Tatsuya Inui
Department of Nursing Management, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
Graduate School of Health Biosciences, The University of Tokushima, Tokushima, Japan
Department of Nursing Management, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
Department of Nursing Management, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan;
Tokushima Prefectural Central Hospital, Tokushima, Japan
Fujishiro Kensei Hospital, Hirosaki, Japan
Fujishiro Kensei Hospital, Hirosaki, Japan
Department of Nursing, Christine E. Lynn College of Nursing, Florida Atlantic University, Boca Raton, USA
Tokushima Prefectural Central Hospital, Tokushima, Japan
Fujii Hospital, Tokushima, Japan
Copyright © 2013 Tetsuya Tanioka, Sakiko Sakamaki, Yuko Yasuhara, Masahito Tomotake, Kensaku Takase, Chie Watari, Kouichi Makiguchi, Rozzano Locsin, Kazushi Motoki, Tatsuya Inui et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Tanioka, T. , Sakamaki, S. , Yasuhara, Y. , Tomotake, M. , Takase, K. , Watari, C. , Makiguchi, K. , Locsin, R. , Motoki, K. and Inui, T. (2013) Optimal needle insertion length for intramuscular injection of risperidone long-acting injectable (RLAI).
Health,
5, 1939-1945. doi:
10.4236/health.2013.512262.